Cattle Remedies India Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
- Paid Up Capital ₹ 2.22 Cr
- Company Age 32 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 0.75 M
- Revenue Growth -95.21%
- Profit Growth 151.90%
- Ebitda 74.91%
- Net Worth 3.11%
- Total Assets -0.57%
About Cattle Remedies India
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239DL1992PLC048964
-
Company No.
048964
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
29 May 1992
-
Date of AGM
30 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cattle Remedies India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Agarwal
|
Managing Director | 29-May-1992 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ajay Agrawal
|
Director | 15-May-1995 | Current |
|
Sanjay Agarwal
|
Director | 15-May-1995 | Current |
Financial Performance of Cattle Remedies India.
Cattle Remedies India Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 95.21% decrease. The company also saw a substantial improvement in profitability, with a 151.9% increase in profit. The company's net worth moved up by a moderate rise of 3.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cattle Remedies India?
In 2017, Cattle Remedies India had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vamso Biotec Private LimitedAjay Agrawal, Mukesh Agarwal and 1 more are mutual person
-
Makams Industries Private LimitedMukesh Agarwal is a mutual person
-
Dalmia Capital LlpAjay Agrawal is a mutual person
-
Ikshan Enterprise Limited
Mukesh Agarwal is a mutual person
-
Omkareshwari Exim Limited
Mukesh Agarwal is a mutual person
-
Makams Biotech Private Limited
Mukesh Agarwal is a mutual person
Charges (Loans)
₹0
₹0.08 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 1999 | Bank Of India | ₹0.75 M | Satisfied |
How Many Employees Work at Cattle Remedies India?
Cattle Remedies India has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cattle Remedies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cattle Remedies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.